ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

11.11

+0.78 (7.55%)

At close: Oct 8, 2025, 4:00 PM EDT

11.16

+0.05 (0.45%)

After-hours: Oct 8, 2025, 6:44 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Needle-free Intranasal	30.00K	Log In
Needle-free Intranasal Growth	-97.72%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.